AU2001255708A1 - Synthesis and use of thienotriazolodiazepines - Google Patents

Synthesis and use of thienotriazolodiazepines

Info

Publication number
AU2001255708A1
AU2001255708A1 AU2001255708A AU5570801A AU2001255708A1 AU 2001255708 A1 AU2001255708 A1 AU 2001255708A1 AU 2001255708 A AU2001255708 A AU 2001255708A AU 5570801 A AU5570801 A AU 5570801A AU 2001255708 A1 AU2001255708 A1 AU 2001255708A1
Authority
AU
Australia
Prior art keywords
thienotriazolodiazepines
synthesis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001255708A
Inventor
Nicholoas G. Bazan
G. Julio Alvarez Builla
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Louisiana State University
Original Assignee
Louisiana State University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Louisiana State University filed Critical Louisiana State University
Publication of AU2001255708A1 publication Critical patent/AU2001255708A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001255708A 2000-04-28 2001-04-26 Synthesis and use of thienotriazolodiazepines Abandoned AU2001255708A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20042000P 2000-04-28 2000-04-28
US60200420 2000-04-28
PCT/US2001/013496 WO2001083440A2 (en) 2000-04-28 2001-04-26 Synthesis and use of thienotriazolodiazepines

Publications (1)

Publication Number Publication Date
AU2001255708A1 true AU2001255708A1 (en) 2001-11-12

Family

ID=22741655

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001255708A Abandoned AU2001255708A1 (en) 2000-04-28 2001-04-26 Synthesis and use of thienotriazolodiazepines

Country Status (3)

Country Link
US (1) US6987105B2 (en)
AU (1) AU2001255708A1 (en)
WO (1) WO2001083440A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6979682B2 (en) 2001-02-23 2005-12-27 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Platelet-activating factor antagonist inhibition of angiogenesis and tumor growth induced by basic fibroblast
EP3563842A1 (en) 2009-04-29 2019-11-06 Amarin Pharmaceuticals Ireland Limited Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0369810A3 (en) 1988-11-18 1991-05-02 Takeda Chemical Industries, Ltd. Paf antagonists as anti-hyperendothelinemia agents
GB8907256D0 (en) * 1989-03-31 1989-05-17 Rech Et D Applic Scient Scras New derivatives of hetrazepine as anti-asthmatic anti-allergic and gastro-intestinal protectors
GB8907257D0 (en) * 1989-03-31 1989-05-17 Rech Et D Applic Scient Scras New derivatives of hetrazepine as anti-paf and anti-ischemic agents
GB8911030D0 (en) * 1989-05-13 1989-06-28 Scras Hetrazepine derivatives
FR2779652B1 (en) * 1998-06-15 2001-06-08 Sod Conseils Rech Applic USE OF DIAZEPINES FOR THE PREPARATION OF MEDICINES FOR THE TREATMENT OF CONDITIONS OR DISEASES IN WHICH ONE OF THE SOMATOSTATIN RECEPTORS IS INVOLVED

Also Published As

Publication number Publication date
WO2001083440A3 (en) 2002-04-25
WO2001083440A2 (en) 2001-11-08
US6987105B2 (en) 2006-01-17
US20030229078A1 (en) 2003-12-11

Similar Documents

Publication Publication Date Title
AU2002320058A1 (en) Magnetic-nanoparticle conjugates and methods of use
AU4520801A (en) Novel substituted phenanthridinones and methods of use thereof
AU2001291859A1 (en) Use of copolycarbonates
AU2002225954A1 (en) Dipeptidylpeptidases and methods of use
AU2002235128A1 (en) Expression miniarrays and uses thereof
AU2002314466A1 (en) Withasol and methods of use
AU2001281850A1 (en) Use of inulin and inulin derivatives
AU2002346548A1 (en) Regioisomerically pure oxochlorins and methods of synthesis
AU2001281140A1 (en) Anti-plasmodium compositions and methods of use
AU2001276440A1 (en) Use and cosmetic compositions of starch betainates
AU2002213422A1 (en) Synthesis of 2-hydroxymethylglutamic acid and congeners thereof
AU3622600A (en) Metalloproteinases and methods of use therefor
AU2002256108A1 (en) Synthesis and use of glycodendrimer reagents
AU2002213346A1 (en) Osteopontin-coated surfaces and methods of use
AU2001293048A1 (en) Antiviral compositions and methods of use
AU2002230781A1 (en) Pharmaceutical uses and synthesis of benzobicyclooctanes
AU2002363938A1 (en) Methods and use of motoneuronotropic factors
AU2001264863A1 (en) Preparation of fagopyritols and uses therefor
AU2001261496A1 (en) Luxo-sigma54 interactions and methods of use
AU2001268236A1 (en) Use of aicar and related compounds
AU4432001A (en) Trityl-type compounds and their use
AU2001274022A1 (en) Use of substituted 1-amino-5-phenylpentane-3-ol and/or 1-amino-6-phenylhexane-3-ol compounds as medicaments
AU4450100A (en) 225Ac-heha and related compounds, methods of synthesis and methods of use
AUPR197000A0 (en) Synthesis of small particles
AU2001255708A1 (en) Synthesis and use of thienotriazolodiazepines